MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Rare Heterozygous SLC25A12 Variants Are Associated with Parkinson’s Disease

    K. Senkevich, T. Kleinz, N. Brüggemann, ZH. Fang, Z. Gan-Or, N. Mencacci, C. Blauwendraat, H. Morris, S. Judd, T. Gasser, K. Brockmann, P. Pastor, C. Beetz, P. Bauer, P. Heutink, K. Seppi, F. Krismer, C. Klein, J. Trinh, A. Zimprich (Montreal, Canada)

    Objective: To identify rare genetic variants contributing to Parkinson’s disease (PD) using analysis of multiplex families and large-scale genomic datasets. Background: Rare variants identified through…
  • 2026 International Congress

    Topographic Heterogeneity of Dopaminergic Denervation and Iron Deposition in Functional Subregions of Nigrostriatal System in Parkinson’s Disease

    YJ. Duan, XL. Liu, XJ. Dan, Y. Li, H. Zhang, HW. Qiao, W. Mao, EH. Xu, SY. Liu, P. Chan (Beijing, China)

    Objective: ​​​​To investigate the spatial relationship between striatal dopaminergic denervation and nigral iron accumulation in Parkinson’s disease (PD) using functional subregional parcellation. Background: Excessive nigral…
  • 2026 International Congress

    Short Term Effects of Wearable Vibrotactile Stimulation in Laryngeal Dystonia

    N. Doan, K. Vo, T. Dang, U. Ha, T. Nguyen, T. Tran (Ho Chi Minh City, Viet Nam)

    Objective: To evaluate the short-term efficacy of a wearable vibrotactile stimulation (VTS) device in patients with laryngeal dystonia (LD) prior to botulinum toxin (BoNT) injection,…
  • 2026 International Congress

    Two Voices, One Disease: Patient and Care Partner Decision Dynamics on Advanced Therapies for Parkinson’s Disease

    W. Zhang, C. Jimenez Moreno, T. Tervonen, G. Al-Jassar, M. Kirchner, M. Penn, T. Machewitz, C. de Vries, A. Gabriel, C. Gøtzsche, J. Lott, A. Merriam Crespo, A. Mitchell, M. de Leon (Berlin, Germany)

    Objective: To characterize decision dynamics between patients with Parkinson’s disease (PwP) and their care partners (CP) on initiation of advanced therapies. Background: Factors guiding decisions…
  • 2026 International Congress

    Clinical Utility of Neurophysiological Tremor Study Within a Joint Neurology-Neurophysiology Movement Disorders Clinic: One-Year Retrospective Two-Center Study

    L. Santos, C. Ordás-Bandera, H. Canfield, L. Yupanqui, A. Gómez, A. Querejeta-Coma (Madrid, Spain)

    Objective: To assess concordance between initial clinical diagnosis and neurophysiological tremor study-based diagnosis, combining surface EMG and accelerometry, and to explore the diagnostic utility of…
  • 2026 International Congress

    Regional Distribution and Concordance of Structural MRI and 18F-FDG PET/MRI Findings in Parkinson-Plus Syndromes

    A. Gunduz, C. Dönmez, F. Bayır, L. Uslu Beşli, O. şahin, H. Apaydın (Istanbul, Turkey)

    Objective: The aim of this study was to evaluate the brain magnetic resonance imaging (MRI) findings and 18F-FDG positron emission tomography/magnetic resonance imaging (PET/MRI) hypometabolism…
  • 2026 International Congress

    Anti-IgLON5 Encephalitis Presenting as Chronic Progressive Asymmetrical Ataxia and Chorea

    P. Kosiyakul, J. Jitprapaikulsan, Y. Pitakpatapee (Bangkok, Thailand)

    Objective: To report a case of gait instability and progressive asymmetrical chorea clinically confirmed as anti-IgLON5 encephalitis. Background: Anti-IgLON5 encephalitis is a rare autoimmune neurological…
  • 2026 International Congress

    Early-Onset Parkinson’s Disease with Early Peak-Dose Dyskinesia: A Case Report

    VD. Tkachenko, MZ. Makoeva, MR. Portnova, AV. Nikitina (Moscow, Russian Federation)

    Objective: To present a case of early-onset Parkinson's disease (EOPD) in a 41-year-old male with good levodopa response but complicated by early development of peak-dose…
  • 2026 International Congress

    Modeling the Genetic Complexity of Parkinson’s Disease: Generation of Patient-Specific iPSCs with Co-occurring SNCA/GBA1 and PRKN/LRRK2 Variants

    L. Murillo-Hernández, M. Bonilla-Toribio, D. Buiza-Rueda, P. Gomez-Garre, L. Muñoz-Delgado, P. Mir, R. Mejías, A. Fontán-Lozano (Sevilla, Spain)

    Objective: This study aimed to generate and characterize human induced pluripotent stem cell (iPSC) lines derived from two Parkinson’s Disease (PD) patients carrying combinations of…
  • 2026 International Congress

    Neuropsychiatric Symptom Evolution Over the First Decade of Biomarker-Defined Parkinson’s Disease

    I. Schoen, J. Wang, S. Xie, C. Caspell-Garcia, E. Mamikonyan, M. Stark, N. Dahodwala, A. Siderowf, R. Dobkin, M. York, D. Weintraub (Philadelphia, USA)

    Objective: To examine the evolution of neuropsychiatric symptoms (NPS) in biomarker-defined Parkinson’s disease over the first decade following diagnosis. Background: Parkinson’s disease (PD) is frequently…
  • « Previous Page
  • 1
  • …
  • 168
  • 169
  • 170
  • 171
  • 172
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley